Reynold Spector Award in Clinical Pharmacology and Translational Medicine
Forecasted
Reynold Spector Award in Clinical Pharmacology and Translational Medicine honors researchers and teachers for excellence in clinical pharmacology, recognizing achievement rather than funding new projects.
Funder: American Society for Pharmacology and Experimental Therapeutics
Due Dates (Anticipated): September 2027 (Nomination deadline)
Funding Amounts: Scientific achievement award rather than funding for a defined research project
Summary: Recognizes excellence in research and/or teaching in clinical pharmacology.
Key Information: Nominees must be older than 45.
Description
The Reynold Spector Award in Clinical Pharmacology and Translational Medicine is a scientific achievement award administered by the American Society for Pharmacology and Experimental Therapeutics (ASPET). It recognizes excellence in research and/or teaching in clinical pharmacology, rather than providing funding for a proposed research project. It belongs to ASPET’s broader scientific achievement awards program, which honors accomplishments in particular areas of pharmacology and contributions to the discipline generally.
ASPET established the award in 2014 in recognition of Dr. Spector’s dedication and contributions to clinical pharmacology. The award is made possible by an endowment from Dr. Reynold and Mrs. Michiko Spector.
